Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 31810585)

  • 1. The association of SOX2 with clinical features and prognosis in colorectal cancer: A meta-analysis.
    Zhang XH; Wang W; Wang YQ; Zhu L; Ma L
    Pathol Res Pract; 2020 Jan; 216(1):152769. PubMed ID: 31810585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of Sox2 expression in digestive tract cancers: A meta-analysis.
    Du XM; Wang LH; Chen XW; Li YX; Li YC; Cao YW
    J Huazhong Univ Sci Technolog Med Sci; 2016 Jun; 36(3):305-312. PubMed ID: 27376796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
    Li Q; Liu F; Zhang Y; Fu L; Wang C; Chen X; Guan S; Meng X
    Oncotarget; 2016 Jun; 7(23):34520-31. PubMed ID: 27150062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX2 contributes to invasion and poor prognosis of gastric cancer: A meta-analysis.
    Tang K; Liu J; Liu B; Meng C; Liao J
    Medicine (Baltimore); 2022 Sep; 101(36):e30559. PubMed ID: 36086709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
    Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
    Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.
    You L; Guo X; Huang Y
    Yonsei Med J; 2018 Jan; 59(1):35-42. PubMed ID: 29214774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SOX2 as prognostic factor in head and neck cancer: a systematic review and meta-analysis.
    Li W; Li B; Wang R; Huang D; Jin W; Yang S
    Acta Otolaryngol; 2014 Nov; 134(11):1101-8. PubMed ID: 25315908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of SOX2 expression in non-small cell lung cancer: a meta-analysis.
    Chen Y; Huang Y; Huang Y; Chen J; Wang S; Zhou J
    PLoS One; 2013; 8(8):e71140. PubMed ID: 23990933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and Clinical Significance of Ki67 and SOX2 in Colorectal Cancer.
    Hu B; Song X; Ding W; Wang H; Cai H; Huang Z
    J Healthc Eng; 2023; 2023():3783631. PubMed ID: 37457497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SOX2 as a prognostic marker and a potential molecular target in cervical cancer: A meta-analysis.
    Yuan D; Wang J; Yan M; Xu Y
    Int J Biol Markers; 2021 Dec; 36(4):45-53. PubMed ID: 34719977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic and clinicopathological value of p16 protein aberrant expression in colorectal cancer: A PRISMA-compliant Meta-analysis.
    Zhou N; Gu Q
    Medicine (Baltimore); 2018 Mar; 97(12):e0195. PubMed ID: 29561443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of SOX2 overexpression in prognosis of patients with solid tumors: A meta-analysis and system review.
    Wang S; Liu X; Chen Y; Zhan X; Wu T; Chen B; Sun G; Yan S; Xu L
    Medicine (Baltimore); 2020 Mar; 99(13):e19604. PubMed ID: 32221082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.
    Saigusa S; Tanaka K; Toiyama Y; Yokoe T; Okugawa Y; Ioue Y; Miki C; Kusunoki M
    Ann Surg Oncol; 2009 Dec; 16(12):3488-98. PubMed ID: 19657699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [LincRNA-ROR functions as a ceRNA to regulate Oct4, Sox2, and Nanog expression by sponging miR-145 and its effect on biologic characteristics of colonic cancer stem cells].
    Yan ZY; Sun XC
    Zhonghua Bing Li Xue Za Zhi; 2018 Apr; 47(4):284-290. PubMed ID: 29690669
    [No Abstract]   [Full Text] [Related]  

  • 15. Astrocyte Elevated Gene-1 as a Novel Clinicopathological and Prognostic Biomarker for Gastrointestinal Cancers: A Meta-Analysis with 2999 Patients.
    Luo Y; Zhang X; Tan Z; Wu P; Xiang X; Dang Y; Chen G
    PLoS One; 2015; 10(12):e0145659. PubMed ID: 26710214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
    PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Long Noncoding RNA CRNDE as a Novel Biomarker in Solid Cancers: An Updated Systematic Review and Meta-Analysis.
    Zhou Y; Wang R; Xu T; Xie P; Zhang Y; Zhang A; Wang X; Yang C; Yang H; Zhu S
    J Cancer; 2019; 10(11):2386-2396. PubMed ID: 31258743
    [No Abstract]   [Full Text] [Related]  

  • 18. SOX2 expression correlates with lymph-node metastases and distant spread in right-sided colon cancer.
    Neumann J; Bahr F; Horst D; Kriegl L; Engel J; Luque RM; Gerhard M; Kirchner T; Jung A
    BMC Cancer; 2011 Dec; 11():518. PubMed ID: 22168803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA CRNDE as a potential prognostic biomarker in solid tumors: A meta-analysis.
    Liang C; Zhang B; Ge H; Xu Y; Li G; Wu J
    Clin Chim Acta; 2018 Jun; 481():99-107. PubMed ID: 29501692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and clinicopathological significance of CapG in various cancers: Evidence from a meta-analysis.
    Lang Z; Chen Y; Zhu H; Sun Y; Zhang H; Huang J; Zou Z
    Pathol Res Pract; 2019 Dec; 215(12):152683. PubMed ID: 31685300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.